Why They Voted: Comments From the Oncology Community
1965: MOPP chemotherapy cures Hodgkin lymphoma
“This was the clearest proof of concept that cancer was/is curable. It gave great impulse to therapeutic research that ultimately improved outcomes in breast, colon, kidney cancer, the leukemias, and most childhood malignancies.”
2006: HPV vaccine approved to prevent cervical cancer
“This advance—if broadly adopted—could lead to the total eradication of cervical cancer globally as well. …Millions could be saved.”
2001: Imatinib transforms treatment for CML
“[Imatinib] not only revolutionized CML, but cancer therapy in general. A targeted agent directed at a cancer-causing gene—it represents the dawn of targeted therapy for cancer.”
1977: PVB cures men with testicular cancer
“Took the most lethal cancer for young men to the most curable.”
1991: Powerful antinausea drugs alleviate major side effect of cancer treatment
“[Antiemetics] permit millions of patients to receive full cancer regimens, delivered in a timely fashion . . . many even continue to work and lead high-functioning lives during treatment.” ■
© 2014. American Society of Clinical Oncology. All rights reserved.
To mark ASCO’s 50th anniversary, the Society called on the oncology community to select the five most pivotal advances in cancer research and patient care over the past 50 years. Now, with more than 2,000 votes cast, ASCO has announced the results on CancerProgress.Net, its interactive website on...